Works by Wang, Yuli


Results: 231
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35

    Identification of optimal dosing schedules of dacomitinib and osimertinib for a phase I/II trial in advanced EGFR-mutant non-small cell lung cancer.

    Published in:
    Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-23912-4
    By:
    • Poels, Kamrine E.;
    • Schoenfeld, Adam J.;
    • Makhnin, Alex;
    • Tobi, Yosef;
    • Wang, Yuli;
    • Frisco-Cabanos, Heidie;
    • Chakrabarti, Shaon;
    • Shi, Manli;
    • Napoli, Chelsi;
    • McDonald, Thomas O.;
    • Tan, Weiwei;
    • Hata, Aaron;
    • Weinrich, Scott L.;
    • Yu, Helena A.;
    • Michor, Franziska
    Publication type:
    Article
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50